Skip to main content

Part of the book series: Current Clinical Neurology ((CCNEU))

  • 275 Accesses

Abstract

Current attempts to treat idiopathic Parkinson’s disease (PD) and parkinsonism with transplants of dopaminergic tissue began in the 1970s, with the grafting of tissue into animal models of parkinsonism. The history of brain transplantation, however, is over a century old, dating at least back to the unsuccessful attempts by W.G. Thompson in 1890 to transplant adult cortex to adult cortex in cats and dogs (1). Table 1 lists some of the research precursors of modern fetal tissue efforts.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Thompson, W. G. (1890) Successful brain grafting. NY Med. J. 51, 701–702.

    Google Scholar 

  2. Dunn, E. H. (1917) Primary and secondary findings in a series of attempts to transplant cerebral cortex in the albino rat. J. Comp. Neurol. 27, 565–582.

    Article  Google Scholar 

  3. Halász, B., Pupp, L., and Uhlarik, S. (1962) Hypophysiotrophic area in the hypothalamus. J. Endocr. 25, 147–159.

    Article  PubMed  Google Scholar 

  4. Stenevi, U., Björklund, A., and Svengaard, N. A. (1976) Transplantation of central and peripheral monamine neurons to the adult rat brain: techniques and conditions for survival. Brain Res. 114, 1–20.

    Article  PubMed  CAS  Google Scholar 

  5. Björklund, A. and Stenevi, U. (1979) Reconstruction of the nigrostriatal pathway by intracerebral nigral transplants. Brain Res. 177, 555–560.

    Article  PubMed  Google Scholar 

  6. Perlow, M. J., Freed, W. J., Hoffer, B. J., Seiger, Å., Olson, L., and Wyatt, R. J. (1979) Brain grafts reduce motor abnormalities produced by destruction of nigro-striatal dopamine system. Science 204, 643–647.

    Article  PubMed  CAS  Google Scholar 

  7. Backlund, E.-O., Grandberg, P.-O., Hamberger, B., et al. (1985) Transplantation of adrenal medullary tissue to striatum in parkinsonism: first clinical trials. J. Neurosurg. 62, 169–173.

    Article  PubMed  CAS  Google Scholar 

  8. Jiang, N., Jiang, C., Tang, Z., et al. (1987) Human foetal brain transplant trials in the treatment of Parkinsonism. Acta Acad. Med. Shangai 14, 77.

    Google Scholar 

  9. Brundin, P., Duan, W. M., and Sauer, H. (1994) Functional effects of mesencephalic dopamine neurons and adrenal chromaffin cells grafted to the rodent striatum. In: Functional Neural Transplantation (Dunnett, S. B. and Björklund, A., eds.), Raven Press, New York, pp. 9–46.

    Google Scholar 

  10. Dunnett, S. B. (1998) Repair of the damaged brain. The Alfred Meyer memorial lecture 1998. Neuropath. App. Neurobiol. 25, 351–362.

    Article  Google Scholar 

  11. Björklund, A. (1992) Dopaminergic transplants in experimental parkinsonism: cellular mechanisms of graft-induced functional recovery. Curr. Opin. Neurobiol. 2, 683–689.

    Article  PubMed  Google Scholar 

  12. Annett, L. E. (1994) Functional studies of neural grafts in parkinsonian primates. In: Functional Neural Transplantation (Dunnett, S. B. and Björklund, A., eds.), Raven Press, New York, pp. 71–101.

    Google Scholar 

  13. Krzysztof, S., Plunkett, R. J., Jacobowitz, D. M., Kopin, I. J., and Oldfield, E. H. (1991) Fetal nondopaminergic neural implants in parkinsonian primates. J. Neurosurg. 74, 97–104.

    Article  Google Scholar 

  14. Freed, W. J. (1983) Functional brain tissue transplantation: reversal of lesion-induced rotation by intraventricular substantia nigra and adrenal medulla grafts with a note on intracranial retinal grafts. Biol. Psychiatry 18, 1205–1267.

    PubMed  CAS  Google Scholar 

  15. Bohn, M. C., Marciano, F., Cupit, L., and Gash, D. M. (1988) Recovery of dopaminergic fibers in striatum of the MPTP treated mouse is enhanced by grafts of adrenal medulla. In: Progress in Brain Research, vol. 78 (Gash, D. M. and Sladek, J. R., eds.), Elsevier, Amsterdam, pp. 535–542.

    Google Scholar 

  16. Bankiewicz, K. S., Plunkett, R. J., Kopin, I. J., Jacobowitz, D. M., London, W. T., and Oldfield, E. H. (1988) Transient behavioral recovery in hemiparkinsonian primates after adrenal medullary allografts. In: Progress in Brain Research, vol. 78 (Gash, D. M. and Sladek, J. R., eds.), Elsevier, Amsterdam, pp. 543–549.

    Google Scholar 

  17. Madrazo, I., Drucker-Colin, R., Diaz, V., Martinez-Marta, J., Torres, C., and Becerril, J. J. (1987) Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson’s disease. N. Engl. J. Med. 316, 831–834.

    Article  PubMed  CAS  Google Scholar 

  18. Fahn, S. (1988) Status of transplantation in patients with Parkinson’s disease. American Neurological Association, Soriano Lecture. Philadelphia, PA.

    Google Scholar 

  19. Jiao, S., Zhang, W., Cao, J., Zhang, Z., Wang, H., Ding, M., Zhang Zhuo, Sun, J., Sun, Y., and Shi, M. (1988) Study of adrenal medullary tissue transplantation to striatum in parkinsonism. In: Progress in Brain Research, vol. 78 (Gash, D. M. and Sladek, J. R., eds.), Elsevier, Amsterdam, pp. 575–580.

    Google Scholar 

  20. Allen, G. S., Burns, R. S., Tulipan, N. B., and Parker, R. A. (1989) Adrenal medullary transplantation to the caudate nucleus in Parkinson’s disease. Arch. Neurol. 46, 487–491.

    Article  PubMed  CAS  Google Scholar 

  21. Goetz, C. G., Tanner, C. M., Penn, R. D., Stebbins, G. T., Gilley, D. W., Shannon, K. M., et al. (1990) Adrenal medullary transplant to the striatum of patients with advanced Parkinson’s disease: 1-year motor and psychomotor data. Neurology 40, 273–276.

    Article  PubMed  CAS  Google Scholar 

  22. Velasco, F., Velasco, M., Cuevas, H. R., Jurado, J., Olvera, J., and Jiménez, F. (1991) Autologous adrenal medullary transplants in advanced Parkinson’s disease with particular attention to the selective improvement in symptoms. Stereotact. Funct. Neurosurg. 57, 195–212.

    Article  PubMed  CAS  Google Scholar 

  23. Goetz, C. G., Stebbins, G. T., Klawans, H. L., Koller, W. C., Grossman, R. G., Bakay, R. A. E., Penn, R. D., and UPF Neural Transplantation Registry. (1991) United Parkinson Foundation Neurotransplantation Registry on adrenal medullary transplants: presurgical and 1- and 2-year follow-up. Neurology 41, 1719–1722.

    Article  PubMed  CAS  Google Scholar 

  24. Peterson, D. I., Price, M. L., and Small, C. S. (1989) Autopsy findings in a patient who had an adrenal-to-brain transplant for Parkinson’s disease. Neurology 39, 235–238.

    Article  PubMed  CAS  Google Scholar 

  25. Forno, L. S. and Langston, J. W. (1989) Adrenal medullary transplant to the brain for Parkinson’s disease. Neuropathology of an unsuccessful case. J. Neuropathol. Exp. Neurol. 48(Abstr.), 339.

    Article  Google Scholar 

  26. Hirsch, E. C., Duyckaerts, C., Javoy-Agid, F., Hauw, J.-J., and Agid, Y. (1990) Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson’s disease? Ann. Neurol. 27, 676–682.

    Article  PubMed  CAS  Google Scholar 

  27. Strada, O., Hirsch, E. C., Javoy-Agid, F., Duyckaerts, C., Hauw, J.-J., and Agid, Y. (1993) Low affinity nerve growth factor receptor, adrenal transplant and Parkinson’s disease. J. Neurol. Sci. 120, 33–37.

    Article  PubMed  CAS  Google Scholar 

  28. Hurtig, H., Joyce, J., Sladek, J. R., and Trojanowski, J. Q. (1989) Postmortem analysis of adrenal-medulla-to-caudate autograft in a patient with Parkinson’s disease. Ann. Neurol. 25, 607–614.

    Article  PubMed  CAS  Google Scholar 

  29. Kordower, J. H., Cochran, E., Penn, R. D., and Goetz, C. G. (1991) Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson’s disease. Ann. Neurol. 29, 405–412.

    Article  PubMed  CAS  Google Scholar 

  30. Waters, C., Itabashi, H. H., Apuzzo, M. L. J., and Weiner, L. P. (1990) Adrenal to caudate transplantation: postmortem study. Mov. Disord. 5, 248–250.

    Article  PubMed  CAS  Google Scholar 

  31. Dohan, F. C., Robertson, J. T., Feler, C., Schweitzer, J., Hall, C., and Robertson, J. H. (1988) Autopsy findings in a Parkinson’s disease patient treated with adrenal medullary to caudate nucleus transplant. Soc. Neurosci. Abstr. 1, 8.

    Google Scholar 

  32. Fazzini, E., Dwork, A. J., Blum, C., Burke, R., Coté, L., Goodman, R. R., et al. (1991) Stereotaxic implantation of autologous adrenal medulla into caudate nucleus in four patients with parkinsonism. Arch. Neurol. 48, 813–820.

    Article  PubMed  CAS  Google Scholar 

  33. Jankovic, J., Grossman, R., Goodman, C., Pirozzolo, F., Schneider, L., Zhu, Z., et al. (1989) Clinical, biochemical, and neuropathologic findings following transplantation of adrenal medulla to the caudate nucleus for treatment of Parkinson’s disease. Neurology 39, 1227–1234.

    Article  PubMed  CAS  Google Scholar 

  34. Lindvall, O., Rehncrona, S., Gustavii, B., Brundin, P., Astedt, B., Widner, H., et al. (1988) Fetal dopamine-rich mesencephalic grafts in Parkinson’s disease. Lancet 2, 1483–1484.

    Article  PubMed  CAS  Google Scholar 

  35. Madrazo, I., Leon, V., Torres, C., Aguilera, M. C., Varela, G., Alvarez, F., et al. (1988) Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson’s disease. N. Engl. J. Med. 318, 51.

    PubMed  CAS  Google Scholar 

  36. Lindvall, O. (1998) Update on fetal transplantation: the Swedish experience. Mov. Disord. 13(Suppl. 1), 83–87.

    PubMed  Google Scholar 

  37. Freeman, T. B., Hauser, R. A., and Sanberg, P. R. (1999) Fatal transplant cyst. J. Neurosurg. 90, 1148–1150.

    PubMed  CAS  Google Scholar 

  38. Freeman, T. B., Sanberg, P. R., Nauert, G. M., Boss, B. D., Spector, D., Olanow, C. W., and Kordower, J. H. (1995) Influence of donor age on the survival of solid and suspension intraparenchymal human embryonic micrografts. Cell Transplant. 4, 141–154.

    Article  PubMed  CAS  Google Scholar 

  39. Freeman, T. B., Spence, M. S., Boss, B. D., Spector, D. H., Strecker, R. E., Olanow, C. W., and Kordower, J. H. (1991) Development of dopaminergic neurons in the human substantia nigra. Exp. Neurol. 113, 344–353.

    Article  PubMed  CAS  Google Scholar 

  40. Verney, C., Zecevic, N., Nikolic, B., Alvarez, C., and Berger, B. (1991) Early evidence of catecholaminergic cell groups in 5- and 6–233k-old human embryos using tyrosine hydroxylase and dopamine-B-hydroxylase immunocytochemistry. Neurosci. Lett. 131, 121–124.

    Article  PubMed  CAS  Google Scholar 

  41. Spencer, D. D., Robbins, R. J., Narftolin, F., Marek, K. L., Vollmer, T., Leranth, C., et al. (1992) Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson’s disease. N. Engl. J. Med. 327, 1541–1548.

    Article  PubMed  CAS  Google Scholar 

  42. Freed, C. R., Breeze, R. E., Rosenberg, N. L., Schneck, S. A., Kriek, E., Zi, J.-X., et al. (1992) Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson’s disease. N. Engl. J. Med. 327, 1549–1555.

    Article  PubMed  CAS  Google Scholar 

  43. Freeman, T. B., Olanow, C. W., Hauser, R. A., Nauert, G. M., Smith, D. A., Borlongan, C. V., et al. (1995) Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson’s disease. Ann. Neurol. 38, 379–388.

    Article  PubMed  CAS  Google Scholar 

  44. Pakkenberg, B., Moller, A., Gunderson, H. J., Mouritzen Dam, A., and Pakkenberg, H. (1991) The absolute number of nerve cells in the substantia nigra of normal subjects and in patients with Parkinson’s disease estimated with an unbiased stereological method. J. Neurol. Neurosurg. Psychiatry 54, 30–33.

    Article  PubMed  CAS  Google Scholar 

  45. Brundin, P., Strecker, R. E., Clarke, D. J., Widner, H., Nilsson, O. G., Astedt, B., Lindvall, O., and Bjorklund, A. (1988) Can human fetal dopamine neuron grafts provide a therapy for Parkinson’s disease. Prog. Brain Res. 78, 441–448.

    Article  PubMed  CAS  Google Scholar 

  46. Brundin, P., Strecker, R. E., Widner, H., Clarke, D. J., Nilsson, O. G., Astedt, B., Lindvall, O., and Bjorklund, A. (1988) Human fetal dopamine neurons grafted in a rat model of Parkinson’s disease: immunological aspects, spontaneous and drug-induced behaviour and dopamine release. Exp. Brain Res. 70, 192–208.

    PubMed  CAS  Google Scholar 

  47. Kordower, J. K., Rosenstein, R. M., Collier, T. J., Burke, M. A., Chen, E.-Y., Li, J. M., et al. (1996) Functional fetal nigral grafts in a patient with Parkinson’s disease: chemoanatomic, ultrastructural and metabolic studies. J. Comp. Neurol. 370, 203–230.

    Article  PubMed  CAS  Google Scholar 

  48. Peschanski, M., Defer, G., N’Guyen, J. P., Ricolfi, F., Monfort, J. C., Remy, P., et al. (1994) Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson’s disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 117, 487–499.

    Article  PubMed  Google Scholar 

  49. Madrazo, I., Franco-Bourland, R., Ostrosky-Solis, F., Aguilera, M., Cuevas, C., Zamorano, C., et al. (1990) Fetal homotransplants (ventral mesencephalon and adrenal tissue) to the striatum of Parkinsonian subjects. Arch. Neurol. 47, 1281–1285.

    Article  PubMed  CAS  Google Scholar 

  50. Molina, H., Quinones, R., Alvarez, L., Galarrage, J., Piedra, J., Suarez, C., et al. (1991) Transplantation of human fetal mesencephalic tissue in caudate nucleus as treatment for Parkinson’s disease: the Cuban experience. In: Intracerebral Transplantation in Movement Disorders (Lindvall, O., Bjorklund, A., and Widner, H., eds.), Elsevier Science Publishers, Amsterdam, pp. 99–110.

    Google Scholar 

  51. Lopez-Lozano, J. J., Bravo, G., Brera, B., Millan, I., Dargallo, J., Salmean, J., Uria, J., Insausti, J., and the Clinica Puerta de Hierro neural transplantation group. (1997) Long-term improvement in patients with severe Parkinson’s disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: 5-year follow up in 10 patients. J. Neurosurg. 86, 931–942.

    Article  PubMed  CAS  Google Scholar 

  52. Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W.-Y., DuMouchel, W., Kao, R., et al. (2001) Embryonic dopamine cell transplantation for advanced Parkinson’s disease: a double-blind neurosurgical trial. N. Engl. J. Med. 344, 710–719.

    Article  PubMed  CAS  Google Scholar 

  53. Henderson, B. T., Clough, C. G., Hughes, R. C., Hitchcock, E. R., and Kenny, B. G. (1991) Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson’s disease. Arch. Neurol. 48, 822–827.

    Article  PubMed  CAS  Google Scholar 

  54. Kordower, J. H., Styren, S., Clarke, M., DeKoskey, S. T., Olanow, C. W., and Freeman, T. B. (1997) Fetal grafting for Parkinson’s disease: expression of immune markers in two patients with functional fetal nigral implants. Cell Transplant. 6, 213–219.

    Article  PubMed  CAS  Google Scholar 

  55. Langston, J. W., Widner, H., Goetz, C. G., Brooks, D., Fahn, S., Freeman, T., and Watts, R. (1992) Core assessment program for intracerebral transplantations (CAPIT). Mov. Disord. 7. 2–13.

    Article  PubMed  CAS  Google Scholar 

  56. Defer, G. L., Widner, H., Marie, R. M., Remy, P., and Levivier, M. (1999) Core assessment program for surgical interventional therapies in parkinson’s disease (CAPSIT-PD). Mov. Disord. 14, 572–584.

    Article  PubMed  CAS  Google Scholar 

  57. Widner, H., Tetrud, J., Rehncrona, S., Snow, B., Brundin, P., Gustavii, B., et al. (1992) Bilateral fetal mesencephalic grafting in two patients with Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N. Engl. J. Med. 327, 1556–1563.

    Article  PubMed  CAS  Google Scholar 

  58. Wenning, G. K., Odin, P., Morrish, P., Rehncrona, S., Widner, H., Brundin, P., et al. (1997) Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson’s disease. Ann. Neurol. 42, 95–107.

    Article  PubMed  CAS  Google Scholar 

  59. Hauser, R. A., Freeman, T. B., Snow, B. J., Nauert, M., Gauger, L., Kordower, J. H., and Olanow, C. W. (1999) Longterm evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch. Neurol. 56, 179–187.

    Article  PubMed  CAS  Google Scholar 

  60. Defer, G.-L., Geny, C., Ricolfi, F., Fenelon, G., Monfort, J.-C., Remy, P., et al. (1996) Long-term outcome of unilaterally transplanted parkinsonian patients. Brain 119, 41–50.

    Article  PubMed  Google Scholar 

  61. Kopyov, O. V., Jacques, D., Lieberman, A., Duma, C. M., and Rogers, R. L. (1996) Clinical study of fetal mesencephalic intracerebral transplants for the treatment of Parkinson’s disease. Cell Transplant. 5, 327–337.

    Article  PubMed  CAS  Google Scholar 

  62. Kopyov, O. V., Jacques, D., Lieberman, A., Duma, C. M., and Rogers, R. L. (1997) Outcome following intrastriatal fetal mesencephaoic grafts for Parkinson’s patients is directly related to the volume of grafted tissue. Exp. Neurol. 146, 536–545.

    Article  PubMed  CAS  Google Scholar 

  63. Subrt, O., Tichy, M., Vladyka, V., and Hurt, K. (1991) Grafting of fetal dopamine neurons in Parkinson’s disease: the Czech experience with severe akinetic patients. Acta Neurochirurg. Suppl. 52, 51–53.

    Article  CAS  Google Scholar 

  64. Iacono, R. P., Tang, Z. S., Mazziotta, J. C., Grafton, S., and Hoehn, M. (1992) Bilateral fetal grafts for Parkinson’s disease: 22 months’ results. Stereotact. Funct. Neurosurg. 58, 84–87.

    Article  PubMed  CAS  Google Scholar 

  65. Levivier, M., Dethy, S., Rodesch, F., Peschanski, M., Vandesteene, A., David, P., et al. (1997) Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson’s disease. Stereotact. Funct. Neurosurg. 69, 99–111.

    Article  PubMed  CAS  Google Scholar 

  66. Mendez, I., Dagher, A., Hong, M., Hebb, A., Gaudet, P., Law, A., et al. (2000) Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line-derived neurotrophic factor in patients with Parkinson’s disease. J. Neurosurg. 92, 863–869.

    Article  PubMed  CAS  Google Scholar 

  67. Benabid, A. L., Pollak, P., Gao, D., Hoffmann, D., Limousin, P., Gay, E., et al. (1996) Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J. Neurosurg. 84, 203–214.

    Article  PubMed  CAS  Google Scholar 

  68. Folkerth, R. D. and Durso, R. (1996) Survival and proliferation of nonneural tissues, with obstruction of cerebral ventricles. in a parkinsonian patient treated with fetal allografts. Neurology 46, 1219–1225.

    Article  PubMed  CAS  Google Scholar 

  69. Mamelak, A. N., Eggerding, F. A., Oh, D. S., Wilson, E., Davis, R. L., Spitzer, R., et al. (1998) Fatal cyst formation after fetal mesencephalic allograft transplant for Parkinson’s disease. J. Neurosurg. 89, 592–598.

    Article  PubMed  CAS  Google Scholar 

  70. Redmond. D. E. Jr.. Leranth, C., Spencer, D. D., et al. (1990) Fetal neural graft survival. Lancet 336, 820–822.

    Article  PubMed  Google Scholar 

  71. Hitchcock, E. H., Whitewell, H. L., Sofroniew, M. V., and Bankiewicz, K. S. (1994) Survival of TH-positive and neuromelanin-containing cells in patients with Parkinson’s disease after intrastriatal grafting of fetal ventral mesencephalon (Abs). Exp. Neurol. 129, 3.

    Article  Google Scholar 

  72. Freed, C. R., Trojanowski, J. Z., Galvin, J. E., Rosenstein, J. M., Breeze, R. E., Greene, P. E., et al. (1997) Embryonic dopamine cells cultured as strands show long term survival without immunosuppression in a patient with advanced Parkinson’s disease. Soc. Neurosci. Abstr. 23, 1682.

    Google Scholar 

  73. Kordower, J. H., Freeman, T. B., and Olanow, C. W. (1998) Neuropathology of fetal nigral grafts in patients with Parkinson’s disease. Mov. Disord. 13(Suppl. 1), 88–95.

    PubMed  Google Scholar 

  74. Lawson, H. W., Atrash, H. K., Saftlas, A. F., Koonin, L. M., Ramick, M., and Smith, J. C. (1988) Abortion surveillance, US 1984–1985. Morbid. Mortal. Wkly Rep. 38, 11–42.

    Google Scholar 

  75. Rosenblad, C., Martinez-Serrano, A., and Bjorklund, A. (1996) Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. Neuroscience 75, 979–985.

    Article  PubMed  CAS  Google Scholar 

  76. Granholm, A.-C., Mott, J. L., Bowenkamp, K., Eken, S., Henry, S., Hoffer, B. J., et al. (1997) Glial cell lin-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum. Exp. Brain Res. 116, 29–38.

    Article  PubMed  CAS  Google Scholar 

  77. Yurek, D. M., Lu, W., Hipkens, S., and Wiegand, S. J. (1996) BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons. Exp. Neurol. 137, 105–118.

    Article  PubMed  CAS  Google Scholar 

  78. Espejo, M., Cutillas, B., Arenas, E., and Ambrosio, S. (2000) Increased sruvival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor. Cell Transplant. 9, 45–53.

    PubMed  CAS  Google Scholar 

  79. Bjorklund, A., Spenger, C., and Stromberg, I. (1997) Tirilazad mesylate increases dopaminergic neuronal survival in the in Oculo grafting model. Exp. Neurol. 148, 324–333.

    Article  PubMed  CAS  Google Scholar 

  80. Schierle, G. S. K., Hansson, O., and Brundin, P. (1999) Flunarizine improves the survival of grafted dopaminergic neurons. Neuroscience 94, 17–20.

    Article  Google Scholar 

  81. Deacon, T., Schumacher, J., Dinsmore, J., et al. (1997) Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson’s disease. Nature Med. 3, 350–353.

    Article  PubMed  CAS  Google Scholar 

  82. Schumacher, J. M., Ellias, S. A., Palmer, E. P., Kott, H. S., Dinsmore, J., Dempsey, P. K., et al. (2000) Transplantation of embryonic porcine mesencephalic tissue in patients with PD. Neurology 54, 1042–1050.

    Article  PubMed  CAS  Google Scholar 

  83. Watts, R. L., Freeman, T. L., Hauser, R. A., Bakay, R. A., Ellias, S. A., Stoessl, A. J., et al. (2001) A double-blind, randomized, controlled, multicenter clinical trial of the safety and efficacy of stereotaxic intrastriatal implantation of fetal porcine ventral mesencephalic tissue (NeurocellTM-PD) vs. imitation surgery in patients with Parkinson’s disease (PD). Parkinsonism Rel. Disord. 7(Suppl.), S87.

    Google Scholar 

  84. Patience, C., Takenchi, Y., and Weiss, R. A. (1997) Infection of human cells by an endogenous retrovirus of pigs. Nature Med. 3, 282–286.

    Article  PubMed  CAS  Google Scholar 

  85. Bankiewicz, K. S., Leff, S. E., Nagy, D., Jungles, S., Rokovich, J., Spratt, K., et al. (1997) Practical aspects of the development of ex vivo and in vivo gene therapy for Parkinson’s disease. Exp. Neurol. 144, 147–156.

    Article  PubMed  CAS  Google Scholar 

  86. Date, I. and Ohmoto, T. (1999) Neural transplantation for Parkinson’s disease. Cell Mol. Neurobiol. 19, 67–78.

    Article  PubMed  CAS  Google Scholar 

  87. Uchida, K., Roach, A. H., Kawaja, M. D., and Toya, S. (1999) Successful survival of grafted transgenic neural plate cells in adult central nervous system environment. Cell Mol. Neurobiol. 19, 79–86.

    Article  PubMed  CAS  Google Scholar 

  88. Bentlage, C., Nikkhah, G., Cunningham, M. G., and Bjorklund, A. (1999) Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host. Exp. Neurol. 159, 177–190.

    Article  PubMed  CAS  Google Scholar 

  89. Dunnett, S. B., Rogers, D. C., and Richards, S.-J. (1989) Nigrostriatal reconstruction after 6-OHDA lesion in rats: combination of dopamine-rich nigral grafts and nigrostriatal “bridge” grafts. Exp. Brain Res. 75, 523–535.

    Article  PubMed  CAS  Google Scholar 

  90. Zhou, F. C. and Chiang, Y. H. (1995) Excitochemical-induced trophic bridging directs axonal growth of transplanted neurons to distal target. Cell Transplant. 4, 103–112.

    Article  PubMed  CAS  Google Scholar 

  91. Mendez, I., Sadi, D., and Hong, M. (1996) Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants. J. Neurosci. 16, 7216–7227.

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Greene, P., Fahn, S. (2003). Fetal Tissue Transplantation for the Treatment of Parkinson’s Disease. In: Tarsy, D., Vitek, J.L., Lozano, A.M. (eds) Surgical Treatment of Parkinson’s Disease and Other Movement Disorders. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-312-5_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-312-5_22

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9736-6

  • Online ISBN: 978-1-59259-312-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics